Post by
Shriver9 on Nov 01, 2020 8:23pm
One reason for FDA deprioritization
On doing a Google seach for "FDA Deprioritization", I came across an article " FDA Winners and Losers in COVID19 Therapies" dated 3rd July. Paragraph 6, explains why some plausible COVID therpies are deprioritized - time required for manufacturing and scaling up. A FDA director is quoted as saying “We’re seeing so much delay in bringing products to market because folks just are not paying attention to the manufacturing issues.”
This "criteria" for deprioritization was public knowledge in early July, long before Sona submitted their FDA EUA application. We cannot just blame it on recent changes to FDA templates or politics.
https://www.pharmaceutical-technology.com/comment/fda-winners-losers-covid-19-therapies/
Comment by
Nonesense64 on Nov 01, 2020 8:33pm
Exactly. That is why Regan said manufacturing was limited. So, having known that, one would have admit that negligence played a big part in Sona not being prioritizef.
Comment by
erfre16 on Nov 01, 2020 8:53pm
Very interesting Very nice find
Comment by
Allforoilandgas on Nov 02, 2020 5:29am
The only reason for US deprioritization is that they are the ones selling their tests to Canada. So why would they aprove testers made in Canada.It is A no brainer for them.Canada is the only country that to leave this happen and know what is going on WOW they did it to us again . Come on wake up Canada.
Comment by
danjones20000 on Nov 02, 2020 12:36pm
Sona has no manufacturing capabilities, thats the reason for deprioritization. These idiots at Sona knew they weren't going to get approval from FDA for EUA and they dragged everyone along for no reason. I am very doubtful HC will give IO, its gonna be the same problem no manufacturing capabilities.